D.E. Shaw & Co’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-118,828
| Closed | -$695K | – | 3436 |
|
|
2024
Q3 | $695K | Sell |
118,828
-86,773
| -42% | -$508K | ﹤0.01% | 2331 |
|
|
2024
Q2 | $1.63M | Sell |
205,601
-28,388
| -12% | -$225K | ﹤0.01% | 1941 |
|
|
2024
Q1 | $2.18M | Sell |
233,989
-172,055
| -42% | -$1.6M | ﹤0.01% | 1726 |
|
|
2023
Q4 | $3.43M | Sell |
406,044
-220,079
| -35% | -$1.86M | ﹤0.01% | 1452 |
|
|
2023
Q3 | $4.85M | Sell |
626,123
-321,850
| -34% | -$2.49M | 0.01% | 1196 |
|
|
2023
Q2 | $10.9M | Buy |
947,973
+319,501
| +51% | +$3.66M | 0.01% | 835 |
|
|
2023
Q1 | $4.85M | Sell |
628,472
-60,228
| -9% | -$464K | 0.01% | 1353 |
|
|
2022
Q4 | $4.2M | Sell |
688,700
-16,076
| -2% | -$98.1K | ﹤0.01% | 1560 |
|
|
2022
Q3 | $4.17M | Sell |
704,776
-22,366
| -3% | -$132K | 0.01% | 1612 |
|
|
2022
Q2 | $4.3M | Buy |
727,142
+90,921
| +14% | +$537K | 0.01% | 1700 |
|
|
2022
Q1 | $4.85M | Buy |
636,221
+342,198
| +116% | +$2.61M | ﹤0.01% | 1698 |
|
|
2021
Q4 | $797K | Buy |
+294,023
| New | +$797K | ﹤0.01% | 2866 |
|
|
2020
Q3 | – | Sell |
-19,927
| Closed | -$251K | – | 2803 |
|
|
2020
Q2 | $251K | Sell |
19,927
-16,776
| -46% | -$211K | ﹤0.01% | 2389 |
|
|
2020
Q1 | $336K | Sell |
36,703
-153,303
| -81% | -$1.4M | ﹤0.01% | 2294 |
|
|
2019
Q4 | $2.65M | Buy |
190,006
+14,620
| +8% | +$204K | ﹤0.01% | 1483 |
|
|
2019
Q3 | $3.02M | Sell |
175,386
-88,076
| -33% | -$1.52M | ﹤0.01% | 1392 |
|
|
2019
Q2 | $7.17M | Buy |
263,462
+22,857
| +9% | +$622K | 0.01% | 995 |
|
|
2019
Q1 | $4.61M | Buy |
240,605
+201,274
| +512% | +$3.85M | 0.01% | 1177 |
|
|
2018
Q4 | $370K | Buy |
+39,331
| New | +$370K | ﹤0.01% | 2191 |
|
|
2017
Q4 | – | Sell |
-10,621
| Closed | -$219K | – | 2665 |
|
|
2017
Q3 | $219K | Buy |
+10,621
| New | +$219K | ﹤0.01% | 2329 |
|